Advancements in Cardiovascular and Antidiabetic Drug Therapy
The aim of this reprint is to immerse the reader in the transformative advancements in drug-based therapies for cardiovascular diseases and diabetes, two major contributors to global morbidity and mortality. From the groundbreaking use of sodium–glucose cotransporter 2 inhibitors in heart failure an...
Saved in:
| Format: | Online |
|---|---|
| Language: | English |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| Subjects: | |
| Online Access: | ONIX_20250812T095121_9783725832675_101 |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1869527692202737664 |
|---|---|
| collection | Directory of Open Access Books |
| description | The aim of this reprint is to immerse the reader in the transformative advancements in drug-based therapies for cardiovascular diseases and diabetes, two major contributors to global morbidity and mortality. From the groundbreaking use of sodium–glucose cotransporter 2 inhibitors in heart failure and diabetes management to the development of novel incretin therapies and innovative insulin delivery systems, this collection examines the potential and promise of these cutting-edge pharmacological strategies. In this special issue, leading experts in the fields of cardiology and diabetology share their insights, clinical findings, and visions for the future of integrated therapeutic approaches. Together, we embark on a journey to redefine the prevention and treatment of cardiovascular and metabolic disorders, offering sustainable solutions to improve patient outcomes and quality of life. This Special Issue paves the way towards a healthier, more resilient future where the burden of these interconnected conditions is mitigated by science-driven innovations. |
| format | Online |
| id | doab-20.500.12854ir-165152 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1651522025-08-12T08:06:39Z Advancements in Cardiovascular and Antidiabetic Drug Therapy Caturano, Alfredo cardiovascular diseases antidiabetic drugs pharmacological interventions sodium–glucose cotransporter 2 inhibitors PCSK9 inhibitors obeticholic acid lipid-lowering agents heart failure treatment diabetes management drug therapy innovations thema EDItEUR::M Medicine and Nursing The aim of this reprint is to immerse the reader in the transformative advancements in drug-based therapies for cardiovascular diseases and diabetes, two major contributors to global morbidity and mortality. From the groundbreaking use of sodium–glucose cotransporter 2 inhibitors in heart failure and diabetes management to the development of novel incretin therapies and innovative insulin delivery systems, this collection examines the potential and promise of these cutting-edge pharmacological strategies. In this special issue, leading experts in the fields of cardiology and diabetology share their insights, clinical findings, and visions for the future of integrated therapeutic approaches. Together, we embark on a journey to redefine the prevention and treatment of cardiovascular and metabolic disorders, offering sustainable solutions to improve patient outcomes and quality of life. This Special Issue paves the way towards a healthier, more resilient future where the burden of these interconnected conditions is mitigated by science-driven innovations. 2025-08-12T08:06:35Z 2025-08-12T08:06:35Z 2025 book ONIX_20250812T095121_9783725832675_101 9783725832675 9783725832682 https://directory.doabooks.org/handle/20.500.12854/165152 eng image/jpeg Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/10495 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-3268-2 10.3390/books978-3-7258-3268-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725832675 9783725832682 190 open access |
| spellingShingle | cardiovascular diseases antidiabetic drugs pharmacological interventions sodium–glucose cotransporter 2 inhibitors PCSK9 inhibitors obeticholic acid lipid-lowering agents heart failure treatment diabetes management drug therapy innovations thema EDItEUR::M Medicine and Nursing Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title | Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title_full | Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title_fullStr | Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title_full_unstemmed | Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title_short | Advancements in Cardiovascular and Antidiabetic Drug Therapy |
| title_sort | advancements in cardiovascular and antidiabetic drug therapy |
| topic | cardiovascular diseases antidiabetic drugs pharmacological interventions sodium–glucose cotransporter 2 inhibitors PCSK9 inhibitors obeticholic acid lipid-lowering agents heart failure treatment diabetes management drug therapy innovations thema EDItEUR::M Medicine and Nursing |
| topic_facet | cardiovascular diseases antidiabetic drugs pharmacological interventions sodium–glucose cotransporter 2 inhibitors PCSK9 inhibitors obeticholic acid lipid-lowering agents heart failure treatment diabetes management drug therapy innovations thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20250812T095121_9783725832675_101 |